Due to the low number of MD and CD/CRD patients with biallelic truncating ABCA4 variants, the median age of disease onset was checked by comparing patients with non-truncating variants versus all those who had at least one truncating variant. This evidence concerns the gene ABCA4 and Menkes disease.